Aprilia (Rome), Italy
Our Aprilia, Italy facility houses softgel manufacturing operations for oral and topical applications, including our innovative softgel cosmetics capsules.
Our Aprilia, Italy facility houses softgel manufacturing operations for oral and topical applications, including our innovative softgel cosmetics capsules.
Catalent’s Anagni facility is a world-class, late-stage and commercial product launch site offering sterile and biologics manufacturing and secondary packaging with extensive expertise i…
Catalent Biologics’ drug product development and manufacturing services leverage proven expertise from pre-clinical to commercial launch and supply of small molecules, biologics, vaccines, and biosimi…
Catalent’s Anagni facility is a world-class, late-stage and commercial product launch site offering sterile and biologics manufacturing and secondary packaging with extensive expertise in vial filling for aseptic liquid and powder products.
Bristol-Myers Squibb Company and Catalent, Inc. today announced that Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy.